Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Eliem Therapeutics, Inc. | CHIEF ACCOUNTING OFFICER | Restricted Stock Units | 30K | $239K | $7.98 | Sep 18, 2024 | Direct |
Eliem Therapeutics, Inc. | CHIEF ACCOUNTING OFFICER | Common Stock | 7.56K | $61K | $8.06 | Sep 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ELYM | Eliem Therapeutics, Inc. | Sep 18, 2024 | 4 | -$9.74K | 4 | Sep 20, 2024 | CHIEF ACCOUNTING OFFICER |
ELYM | Eliem Therapeutics, Inc. | Jun 18, 2024 | 3 | -$8.98K | 4 | Jun 21, 2024 | CHIEF ACCOUNTING OFFICER |
ELYM | Eliem Therapeutics, Inc. | Mar 18, 2024 | 1 | $0 | 4 | Mar 20, 2024 | CHIEF ACCOUNTING OFFICER |
ELYM | Eliem Therapeutics, Inc. | Mar 13, 2023 | 0 | $0 | 3 | Mar 21, 2023 | Chief Accounting Officer |